| buprenorphine sublingual tablets / Generic mfg. |
2007-005291-14: Evaluation des seuils nociceptifs chez les patients dépendants aux opiacés sous traitement de substitution par méthadone ou buprénorphine haute dose. |
|
|
| Ongoing | 4 | 128 | Europe | Méthadone chlorhydrate, Subutex, Méthadone chlorhydrate, Subutex | CHU Clermont-Ferrand | Patients inclus dans un programme de substitution par méthadone ou buprénorphine et volontaires sains | | | | |
2007-006523-12: Mejora de la efectividad de los tratamientos de mantenimiento con naltrexona en adictos a opiáceos con la adicción de buprenorfina sublingual. Improvement of naltrexone maintenance treatment effectivity in opiate addict patients adding buprenorphine. |
|
|
| Ongoing | 4 | 200 | Europe | SUBUTEX 8 mg comprimidos sublinguales, REVIA 50 mg comprimidos, SUBUTEX 8 mg comprimidos sublinguales, REVIA 50 mg comprimidos | Julio Bobes | Dependencia de opiáceos. Opiate dependence. | | | | |
NCT04091009: A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms |
|
|
| Not yet recruiting | 4 | 76 | NA | Buprenorphine, Subutex, Buprenorphine/naloxone, Suboxone | Massachusetts General Hospital | Opioid-use Disorder, Opioid Use Disorder, Mild | 12/22 | 12/23 | | |
| Completed | 3 | 9 | US | Buprenorphine, Naloxone, Suboxone, Buprenex, Subutex | Yale University, United States Department of Defense | Opioid Dependence | 02/22 | 01/23 | | |
| Completed | 3 | 342 | Europe | Buprenorphine Injectable Product, Sublocade®; prev. RBP-60000, Methadone, Buprenorphine, Suboxone, Espranor, Subutex | King's College London, South London and Maudsley NHS Foundation Trust, Greater Manchester Mental Health NHS Foundation Trust, Cumbria, Northumberland Tyne and Wear NHS Foundation Trust, Birmingham and Solihull Mental Health NHS Foundation Trust, NHS Tayside, Bangor University | Opiate Substitution Treatment | 04/22 | 03/23 | | |
MOMs-CMA, NCT03911466: Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study |
|
|
| Active, not recruiting | 3 | 97 | US | Buprenorphine Injection, CAM2038, Buprenorphine Sublingual Product, Subutex, Suboxone | T. John Winhusen, PhD, National Institute on Drug Abuse (NIDA), The Emmes Company, LLC | Opioid-Related Disorders, Drug Addiction, Pregnancy Related, Substance Abuse, Drug Abuse, Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal Syndrome, Drug Abuse in Pregnancy | 01/25 | 01/25 | | |
| Active, not recruiting | 3 | 140 | US | Buprenorphine Injection, CAM2038, Buprenorphine Sublingual Product, Subutex, Suboxone | T. John Winhusen, PhD, National Institute on Drug Abuse (NIDA), The Emmes Company, LLC | Opioid-Related Disorders, Drug Addiction, Pregnancy Related, Substance Abuse, Drug Abuse, Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal Syndrome, Drug Abuse in Pregnancy | 01/25 | 01/25 | | |
MOMs-INO, NCT03911739: Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study |
|
|
| Recruiting | 3 | 200 | US | Buprenorphine Injection, CAM2038, Buprenorphine Sublingual Product, Subutex, Suboxone | T. John Winhusen, PhD, National Institute on Drug Abuse (NIDA), The Emmes Company, LLC | Opioid-Related Disorders, Drug Addiction, Pregnancy Related, Substance Abuse, Drug Abuse, Neonatal Abstinence Syndrome, Neonatal Opiate Withdrawal Syndrome, Drug Abuse in Pregnancy | 01/25 | 01/25 | | |
2007-004912-30: Modulation of opiate reward by NK1 antagonism: A laboratory based proof of concept study |
|
|
| Ongoing | 2 | 60 | Europe | Emend, Subutex, Emend, Subutex | Karolinska Institutet | opiate abuse | | | | |
2012-003560-49: Safety & Efficacy of 2 Alternative Forms of Oral Buprenorphine (v10) |
|
|
| Ongoing | 2 | 36 | Europe | Xprenor, Subutex 2 mg sublingual tablets and Subutex 8 mg sublingual tablets, Subutex, Subutex | Macarthys Laboratories Limited (trading as Martindale Pharma), Macarthys Laboratories Limited (trading as Martindale Pharma) | Opioid dependency | | | | |
| Recruiting | N/A | 600 | US | Subutex / Buprenorphine, Fetal & Neonatal MRI, DNA/Genetic/Pharmacokenetic Blood Draws | Senthil Sadhasivam, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA) | Opioid-use Disorder, Opioid Use, Unspecified, Buprenorphine Dependence | 12/24 | 12/25 | | |
| Recruiting | N/A | 1200 | Europe, Canada, US, RoW | | Indivior Inc. | Opioid Use Disorder | 08/27 | 08/27 | | |
